Respiratory Diagnostics Market to Hit USD 9.02 Billion by 2030 with 6.5% CAGR | MarketsandMarkets

DELRAY BEACH, Fla., Feb. 11, 2025 /PRNewswire/ -- The global respiratory diagnostics market, valued at US$ 5.85 billion in 2023, is forecasted to grow at a robust CAGR of 6.5%, reaching US$ 6.17 billion in 2024 and an impressive US$ 9.02 billion by 2030. Respiratory diagnostic devices help detect respiratory disorders. These constitute various instruments, devices, assays, and reagents. Diagnostic tests for respiratory evaluation include mechanical evaluation, such as spirometry, pulse oximetry, and bronchoscopy; imaging studies; and in vitro studies. The market comprises analyzers, sequencers, amplifiers, and electrophoresis systems; assays & reagents; services & software for diagnosing diseases such as tuberculosis, asthma, lung cancer, and chronic obstructive pulmonary disease (COPD).

The major factors driving the growth of this market include the rising incidence of respiratory disorders, the expanding geriatric population and the rise in sedentary lifestyles, growing awareness about respiratory health, and advancements in diagnostic technologies. The high growth potential of emerging economies, the increasing demand for POC testing, and the growing awareness about obstructive sleep apnea (OSA) are factors expected to create growth opportunities for market players during the forecast period.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=163390459

Browse in-depth TOC on 'Respiratory Diagnostics Market'
489 - Tables
71 - Figures
403 - Pages

Growth in the market can be attributed to factors such as increased urbanization, population explosion, increasing smokers, and changing lifestyle patterns. There is also the very poor air quality in several parts of the world, especially in the western world, to add to the existing health conditions established initially by the harmful environmental factors. These include other outdoor factors but seriously include indoor pollution, which increases health problems in general. Children are more prone to develop respiratory diseases like asthma and tuberculosis (TB), chronic obstructive pulmonary disease (COPD), and, to some extent, even more severe complications such as lung cancer and lung failure associated with indoor pollution. Thus, the increasing demand for early detection of these diseases will significantly impact the growth of this market, especially in diagnostics.